Health Library · Medications

Compounded semaglutide shortage

Overview

During the semaglutide shortage, compounding pharmacies produced non-FDA-approved semaglutide. As shortages resolve, most compounded semaglutide is no longer permitted. Quality and safety varies significantly.

Treatment

Clindle prescribes FDA-approved GLP-1s only — Ozempic, Wegovy, Mounjaro, Zepbound — through licensed pharmacies. This protects safety and long-term supply.

When to book a visit

Book to switch from compounded to FDA-approved options or discuss coverage strategies.

Book online today